Adipose-derived stem cells found in fat grafts may have significant healing properties. When fat is combined with autologous platelet-rich plasma (PRP), there may be enhanced healing effects due to the pro-angiogenic and anti-inflammatory effects of PRP. This study aimed to evaluate the current evidence on fat grafting in combination with PRP for wound healing to establish the efficacy of this technique. A comprehensive search in the MEDLINE, EMBASE, CENTRAL, Science Citation Index, and Google Scholar databases (to March 2017) was conducted to identify studies on fat grafting and PRP for wound healing. Case series of less than 3 cases and studies only describing harvest technique were excluded. The database identified 571 articles, of which 3 articles that used a combination of fat and PRP for wound healing (1 RCT and 2 case series) were included in this review. A total of 69 wounds in 64 patients were treated with an average wound size of 36.32cm 2 . Of these, 67% of wounds achieved complete healing. When reported, the mean time to healing was 7.5 weeks for those who underwent a single treatment. There were no significant complications in any patients. The combination of fat grafting and PRP may achieve adequate wound healing with relatively quick wound healing time compared with standard wound management options. However, evidence is extremely limited, and further studies are required to evaluate its efficacy for wound healing.
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| INTRODUCTION
Wound management places a significant burden on health care, costing the National Health Service (NHS) approximately 5.5% of its annual expenditure, 1 equating to billions of pounds per annum. 2 The incidence of chronic wounds and ulcers is greater than 100 000 cases per year, with this number expected to rise due to the ageing population and increasing prevalence of diabetes. 3 Traditional wound management options include regular dressings and skin grafting. Dressing management can often be a slow, timeconsuming process with variable results and 1 in 10 cases in loss of limb. 4 There is no strong evidence base to support the majority of traditional dressing options. 5 Autologous skin grafts are an important wound management option. Standard treatment options primarily consist of full-thickness skin grafts (FTSG) and split-thickness skin grafts (SSG). FTSG consist of the entire epidermis and dermis, and consequently, the donor site must be closed directly after harvest. Therefore, only donor sites with sufficient skin laxity, such as the post-auricular or supraclavicular areas, are suitable for skin harvest, limiting this technique to areas of small wound areas only. 6 FTSG also rely more significantly on the vascularity and nutrients of its recipient bed compared with SSG and, therefore, are at higher risk of graft failure. SSG include the epidermis and part of the dermis and can be meshed to cover a larger wound area and are more versatile with regards to donor sites compared with FTSG. However, the donor site is left to heal by secondary intention, which can cause donor site pain, infection, and scarring. 7 Epidermal grafting is becoming an alternative wound coverage option, with woundhealing rates comparable with SSG with reduced donor site morbidity 8 and higher patient satisfaction. 9 However, evidence on this technique remains very limited. Fat grafting has become increasing popular in contouring procedures over the last few decades 10 ; however, more recently, there is emerging emphasis on its regenerative potential. Adipose-derived stem cells or MSCs found in fat are believed to facilitate healing through differentiation into cells, which effect wound healing, for example, fibroblasts and keratinocytes. 11 They also release pro-healing growth factors and anti-inflammatory cytokines 12 as well as healing-related peptides such as leptin and adiponectin, which together may enhance wound healing. 13 Several small studies have shown that autologous fat grafting may show significant healing qualities in chronically scarred tissue after radiotherapy, 14 chronic wounds, 15, 16 arterial ulcers, 17 pressure ulcers, 18 and diabetic foot ulcers. 19 However, the evidence remains limited, with no randomised controlled trials reported. Platelet-rich plasma (PRP) is an autologous bloodderived product enriched in platelets, growth factors, chemokines, and cytokines. It is a reservoir of essential growth factors, including platelet-derived growth factor, vascular endothelial growth factor, transforming growth factor-beta 1, and insulin-like growth factor, which facilitate repair and healing. Platelet-derived biological mediators have 2 primary effects on wound healing: recruiting and activating cells that effect wound healing and regulation of angiogenesis. 2, 20 Platelets may also have antimicrobial and immune modulation properties, which help to reduce wound infection and facilitate healing. 21 Some studies have found enhanced healing and reduced healing time of split-thickness skin grafts when used in combination with PRP [21] [22] [23] [24] and improved healing when used as the primary treatment for chronic wounds. [25] [26] [27] However, several higher-level evidence studies have shown no clear benefit for wound healing over conventional treatments. [28] [29] [30] When fat and PRP are used in combination, there may be increased survival of the fat graft, which may, in turn, increase the healing properties of the adipose-derived stem cells. This is believed to be due to the pro-angiogenic effects of PRP, which allows early vascularisation of the fat, thus reversing the early ischaemic phase of the graft. 31 Another pro-survival effect may be the release of antiinflammatory chemokines, which help reduce inflammation and swelling, which encourage degeneration of the graft. Hypotheses also exist which suggest that PRP may provide nutrient support to the fat cells through its plasma component and that the fibrin component allows the formation of a scaffold for fat cells. [32] [33] [34] Several studies have
shown that PRP may increase the longevity of fat grafts in contouring procedures. [35] [36] [37] The use of combination fat and PRP for wound healing is beginning to be tested; however, evidence on its efficacy is extremely limited. This systematic review synthesises the current evidence on fat grafting and PRP for wound healing to establish the efficacy of this technique in the clinical setting by measuring the proportion of wounds healed and the mean wound-healing time. It is timely that the evidence is assessed to guide clinical decision making and to facilitate future research.
| MATERIALS AND METHODS
The protocol for this systematic review was registered with PROSPERO international prospective registration of systematic reviews (registration number: CRD42016049881) and has been subsequently published in a peer-reviewed journal. 38 It was intended that this systematic review would be conducted and reported according to the meta-analysis of observational studies in epidemiology (MOOSE) guidelines. 39 However, given the wide heterogeneity between the 3 studies identified, a narrative review was reported, and meta-analysis was not performed.
| SEARCH STRATEGIES
We conducted searches of the MEDLINE (Ovid SP), EMBASE (OvidSP), (CENTRAL), Science Citation Index, and Google Scholar databases from 1946 to March 2017 to identify studies of relevance to this review. The search strategy included a combination of text words and Medical Subject Headings (MeSH) terms relating to the use of fat grafting and PRP for treating wounds. No language or publication restrictions were applied. A sample search strategy for MEDLINE (OvidSP) is shown, and a similar strategy was adapted for other databases.
Key Messages
• fat grafting and platelet-rich plasma, when used in combination, have significant potential to improve wound healing
• the aim of this manuscript was to evaluate the current evi- 
| Inclusion criteria
All animal and human studies evaluating a combination fat grafting and PRP for wound healing were included.
| Exclusion criteria
The exclusion criteria were: case reports or case series of fewer than 3 patients; studies describing only the harvest technique without treatment outcome; and studies evaluating the cellular or molecular outcomes of fat and PRP without assessing wound healing.
| Outcome measures
The primary outcome measures were intended to be the efficacy of EG for wound healing measured by the proportion of wounds healed and the mean wound-healing time (time for complete reepithelialisation). However, given the small number of studies, no specific outcome measures were analysed, and the findings of each paper were discussed descriptively.
| Study selection
The articles' titles and abstracts were scanned for potential eligibility by 2 authors (AK and MP), using the predetermined selection criteria, after excluding duplicate records.
Full-text review was undertaken for studies that met the inclusion criteria. Abstracts and conference proceeding without full text were not included because of the difficulty in evaluating incomplete information. Ongoing trials without complete data were not included. A formal risk of bias assessment was not performed as the included studies were mostly small case series.
| RESULTS

| Literature search results
We found 571 articles in the MEDLINE, EMBASE, and CENTRAL database search. References from these searches were combined, and after removing the duplicates, 380 articles were available for title and abstract reviewing. Of these, 363 articles did not meet the inclusion criteria and were excluded. Following the full-text review of the remaining 17 articles, 14 articles were excluded as the inclusion criteria were not met. A total of 3 articles (1 randomised controlled trial, 2 case series) were included, and data were extracted from these formed the basis of this systematic review. [40] [41] [42] A comprehensive study attrition flow diagram is provided in Figure 1 . Cross-checking of the reference list revealed that no article was missed by the initial search. Details of the included studies are summarised in Table 1 .
| Wound-healing outcomes
In the 3 studies, a total of 69 wounds were treated with a combination of autologous fat and PRP in 64 patients. The average wound size was 36.35 cm 2 (only reported in studies), and the mean age of the patients was 66 years. The number of wounds that achieved complete wound healing was reported in both studies. The total number of wounds achieving full healing was 46, and the proportion of wounds achieving complete healing was 67%. One study reported average time to healing to be 7.5 weeks. 41 The same authors reported that 100% of patients showed wound-healing improvements from 'mild to moderate', which is reported as dermic and epidermic regeneration, although the exact wound size parameters are not reported. One study also reported mean time to complete healing to be 7.5 weeks, although this was only in the 13 patients who underwent a single treatment. 40 The same authors reported that in patients who underwent a second PRP and fat treatment, their time to complete healing was a further 5 weeks, but the time from first treatment was not recorded, so average time to complete healing could not be ascertained. No study reported the rate of partial wound healing or the rate of treatment failure (no change in the size of wound). The combination of fat grafting and PRP was used to treat a wide variety of wound aetiologies, although these were only reported in 2 studies: 'vascular' wounds (n = 27), post-traumatic wound (n = 13), and diabetic ulcers (n = 11). All wounds treated in the studies were chronic. There was no subgroup analysis in either group regarding the efficacy of the treatment for specific wound aetiologies. Only one study 41 reported postoperative complication rates, with 2 cases of wound infection documented. None of the included articles measured the health-related quality of life or patient satisfaction of the treatments. The cost effectiveness of the treatment was also not reported in any study.
| Study Characteristics and Methodology
One study 42 was a poorly reported randomised controlled trial with 2 arms: control group (n = 31 wounds) who received standard dressing care and experiment group (n = 21 wounds) who received a combination of fat and PRP. Details of patient screening, the randomisation process, and enrolment of patients were not included. PRP was obtained through peripheral venopuncture and centrifuging of whole blood. Fat was harvested through standard Coleman technique. 10 The PRP was combined with fat in a 1:1 ratio and injected into wound edges and base. No rationale for the volume of fat injected and size of the wound was provided. A total of 5 mL of activated PRP gel was applied onto the wound. It is reported that patients were followed up weekly for wound management (including further debridement and dressing), but the duration of weekly follow up is not stated, and details of postoperative wound care are not reported. Wound pictures were taken at 1, 3, 6, 12, and 18 months after treatment, and the endpoint of the study for complete healing was 18 months. Patients who underwent fat + PRP treatment had significantly better wound healing (in relation to average size of the wound) compared with the control group, although average time to healing was not measured. One study 41 was a case series of 30 patients with 30 wounds who were treated with PRP and fat grafting plus a hyaluronic acid-medicated biological dressing. The methodology clearly states the inclusion and exclusion criteria and the preoperative assessment and wound care protocol. PRP was obtained through peripheral venopuncture and centrifuge of whole blood. Fat was harvested using a standard Coleman technique and then mixed with PRP in a 1:1 ratio. The volume of the fat:PRP mix infiltrated in relation to the wound size was not reported. Wounds were dressed with a 3-dimensional, polymerised, hyaluronic acidmedicated biological dressing. The rationale, as stated by the authors, for using this dressing was that hyaluronic acid has a synergistic effect with the PRP and allows for better recovery and availability of growth factors, although evidence provided to support this is limited. Wounds were followed up weekly until healing was achieved. At week 2, dressings were removed, and another application of hyaluronic acid was applied, and a further application was performed at week 3 if required; however, the rationale for further applications was not reported. Complete wound healing was observed in 57% of cases, with mean time to healing reported as 7.5 weeks. Wound biopsies were also taken intraoperatively, at 1, 2, and 3 weeks and 1 month post-treatment. Immunohistochemical analysis of the biopsies taken intraoperatively and at 2 weeks showed an increase in cell proliferation indexes for wound repair; however, quantitative data are not provided. One study 40 was a case series of 30 patients with 30 wounds; 18 of these patients were treated with a combination of fat and PRP, 2 patients were treated with PRP alone, and a control group of 10 patients were treated with hyaluronic acid and collagen dressings only. The methodology is unstructured and does not provide clear rationale for evaluating and comparing these different treatments. Inclusion and exclusion criteria of the patients were not reported. Although demographic details of the overall study population were reported, details (including age, gender, wound size, wound duration, aetiology) of the PRP + fat subgroup were not specifically reported. PRP was also obtained through peripheral blood collection and centrifuging in a similar fashion to the other studies. Fat was also harvested through standard Coleman technique. PRP was combined with fat in variable ratios with no clear rationale. Rationale with regards to volume of fat:PRP grafted into each wound in relation to size was not reported. Wounds were 'dressed' with PRP gel. Postoperative follow up was performed at 2 and 5 weeks and then 3, 6, and 12 months and then annually. Details of postoperative wound care were not reported. Thirteen patients underwent a single treatment, and 5 patients underwent a second treatment of PRP and fat. A total of 14 patients achieved complete reepithelialisation (77.8%).
| DISCUSSION
The aim of this systematic review was to evaluate the efficacy of combination fat and PRP for wound healing. We found 3 articles, 1 of which was a poorly reported randomised controlled trial and 2 small case series. Therefore, the current evidence of the efficacy of this treatment is extremely limited. We found that complete healing was achieved in 67% of cases, and although mean time to healing was not accurately reported in any study in those undergoing a single treatment, this was reported to be 7.5 weeks. This outcome is comparable with the healing rate of 73% in split skin grafts 43 and 71.5% in epidermal grafts. 44 There were no reported significant complications or donor site morbidity, with only 2 reported cases of simple wound infection. Although all wounds treated were chronic, there was a lack of complete reporting on the exact aetiology of the wounds treated with no subgroup analysis, and therefore, it is impossible to suggest which wounds the treatment would be most appropriate for. The lack of evidence for this treatment illustrates the fact that it is extremely new, with very few studies evaluating the efficacy in wound healing. There are several studies that have evaluated the regenerative potential of fat grafting. [45] [46] [47] Adipocyte-derived stem cells found within fat grafts are able to differentiate into various cell lineages 48 as well as secrete soluble mediators with angiogenic, immunosuppressive, and anti-inflammatory properties. 49 Several preliminary studies have demonstrated that autologous free fat transfer may significantly enhance the healing of pressure sores, 18,50 critical limb ischaemia, 51 and post-radiation therapy scars. 14 PRP in isolation has also been shown to have significant regenerative properties. [52] [53] [54] [55] [56] [57] These properties are likely to be due to the release of platelet-derived mediators such as platelet-derived growth factor (PDGF), vascular endothelial growth factor (VEGF), transforming growth factor β (TGF-β), and insulin-like growth factor (IGF), 58, 59 which promote the recruitment and activation of cells responsible for tissue repair, and they encourage new blood vessel formation. The addition of PRP to fat grafting has been shown to enhance graft survival through several mechanisms. Firstly, the secretion of pro-angiogenic factors by PRP may improve early graft vascularisation and minimise ischaemic injury 60, 61 ; secondly, the release of antiinflammatory cytokines is thought to have a role in preventing graft degeneration 62, 63 ; and thirdly, PRP-secreted factors have been shown to enhance the differentiation of preadipocytes into their mature form. [64] [65] [66] The majority of human 37, [67] [68] [69] [70] [71] [72] [73] and animal [61] [62] [63] 74, 75 studies suggest that PRP
and fat cotransplantation appears to increase graft survival rates.
However, the benefit of wound healing when PRP and fat are cografted is unproven, and this study has not been able to illustrate a clear benefit over traditional methods. Furthermore, a small but well-reported case series evaluating the efficacy of fat grafting alone in chronic wound healing 19 found an 88% complete wound healing rate, which is significantly better than the pooled rate in this review. The methodology of grafting in both papers was heterogeneous and undertaken without any clear rationale for key decisions, for example, ratio of fat to PRP, volume of graft in relation to wound size, and postoperative wound care. A lack of standardised procedure protocols [76] [77] [78] also limits the usefulness of the evidence presented. However, in the literature, there is no standardised protocol for either PRP 56 or fat grafting in isolation, 79 and there is no evidence to suggest that specific technical factors have a clear outcome of success of the treatment. The evidence in this study is limited by the lack of high-quality level 1 evidence. The existing studies were small case series or poorly reported trials that are often at a risk of bias. There were no comparative data to evaluate the healing outcomes of PRP and fat against the current standard of care, such as advanced dressings or SSG. Formal bias assessment was not performed because of the study design of the included studies. In terms of the search strategy, as there is no MeSH term available for fat grafting or PRP, potentially valuable and informative studies published with other keywords may have therefore been missed.
In conclusion, combination PRP and fat grafting has the potential to be a simple and effective wound treatment option with no significant donor site or graft morbidity. However, our conclusions are greatly limited by the lack of good-quality evidence. A randomised controlled trial to compare combination PRP and fat grafting against standard of care is necessary to fully evaluate the efficacy of this treatment.
